National Research Co. (NASDAQ:NRC - Get Free Report) declared a quarterly dividend on Tuesday, April 29th, Wall Street Journal reports. Investors of record on Friday, June 27th will be given a dividend of 0.12 per share on Friday, July 11th. This represents a $0.48 annualized dividend and a yield of 3.76%. The ex-dividend date of this dividend is Friday, June 27th.
National Research Stock Up 5.5 %
NASDAQ:NRC traded up $0.66 on Friday, hitting $12.77. 97,269 shares of the company's stock traded hands, compared to its average volume of 95,056. The company has a market cap of $293.02 million, a PE ratio of 12.16 and a beta of 0.34. National Research has a 1 year low of $9.76 and a 1 year high of $35.81. The company has a current ratio of 0.47, a quick ratio of 0.47 and a debt-to-equity ratio of 1.30. The firm has a 50-day moving average price of $12.91 and a 200-day moving average price of $16.26.
National Research (NASDAQ:NRC - Get Free Report) last announced its quarterly earnings data on Monday, April 28th. The company reported $0.25 EPS for the quarter. The firm had revenue of $33.55 million for the quarter. National Research had a net margin of 17.32% and a return on equity of 66.52%.
About National Research
(
Get Free Report)
National Research Corporation provides analytics and insights that facilitate measurement and enhancement of the patient and employee experience. Its portfolio of subscription-based solutions provides actionable information and analysis to healthcare organizations across a range of mission-critical, constituent-related elements, including patient experience, service recovery, care transitions, employee engagement, reputation management, and brand loyalty.
Recommended Stories
Before you consider National Research, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and National Research wasn't on the list.
While National Research currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's list of ten stocks that are set to soar in Spring 2025, despite the threat of tariffs and other economic uncertainty. These ten stocks are incredibly resilient and are likely to thrive in any economic environment.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
